USANA HEALTH SCIENCES INC (USNA)

↓ Download CSV

CIK 0000896264 · NYSE · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Incorporated UT
  • Fiscal year ends Jan 3

In fiscal 2026, USANA HEALTH SCIENCES INC reported revenue of $925.26M. The company was profitable, with a net margin of 1.2% and a gross margin of 78.3%. It held $742.91M in total assets against $156.64M in total liabilities.

Key ratios (FY2026)

78.3%
Gross margin
4.0%
Operating margin
1.2%
Net margin
2.0%
Return on equity
Metric (FY)2026202420232022202120192018201720162015
Revenue$925.26M$854.50M$921.01M$998.60M$1.13B$1.06B$1.19B
Cost of Revenue$200.85M$161.21M$176.69M$193.89M$209.11M$187.50M$200.71M$179.40M$180.19M
Gross Profit$724.40M$693.29M$744.32M$804.71M$925.53M$873.40M$988.54M$867.86M$825.89M$649.68M
Operating Income$37.43M$66.32M$93.07M$107.61M$176.49M$146.19M$188.35M$132.50M$138.62M$116.10M
Net Income$10.76M$42.03M$63.79M$69.35M$124.66M$100.53M$126.22M$62.53M$100.04M$76.64M
EPS (Diluted)$0.58$2.19$3.30$3.59$5.86$4.41$5.12$2.53$3.99$2.80
Total Assets$742.91M$748.19M$632.76M$596.55M$640.89M$516.93M$554.46M$519.27M$470.64M$350.58M
Total Liabilities$156.64M$161.86M$135.56M
Shareholders' Equity$533.10M$532.11M$497.20M$434.47M$441.65M$351.71M$391.15M$363.21M$325.29M$230.16M
Cash & Equivalents$158.38M$181.77M$330.42M$288.42M$311.92M$234.83M$214.33M$247.13M$175.77M$111.13M
Operating Cash Flow$22.35M$60.99M$70.64M$103.90M$160.40M$126.73M$152.12M$123.77M$136.89M$105.19M
Capital Expenditures$13.82M$10.07M$14.49M$10.40M$15.09M$16.57M$11.43M$13.22M$32.70M$20.42M
Shares Outstanding18.28M19.06M19.13M19.21M21.04M21.66M23.57M24.02M24.48M12.63M